John Deere Introduces New Planter Technologies to Maximize Efficiency

Mar 13, 2025

OLATHE, Kansas — John Deere (NYSE: DE) announced today new planter technologies designed to make the planting process more efficient, giving farmers an edge in getting the crop in during tight windows due to weather and other conditions. Three new technologies — seed-level sensing, fertilizer-level sensing and active vacuum automation — give farmers more information needed to keep planters running.

Seed-Level Sensing

This logistics improvement provides farmers with a more accurate look at the level of seed remaining in the tank. Currently, farmers estimate time to empty based on previous experience or general visual indicators and often have to stop and manually check the seed levels remaining in the tank. Seed-level sensing places a sensor in the tank that can measure the volume of seed left in the tank, which is then provided to the operator in the cab and the John Deere Operations Center^™. This new feature provides more accurate information on when and where to have seed tenders available for tank refills. This feature is available on model year 2026 planters or as a precision upgrade for certain models back to model year 2022.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.